Gleason score 6

Gleason score 6 – Should we keep calling it cancer?

Bárbara Melão, Urologist in Oncology Department, Manaus Adventist Hospital, shared a post on X:

“PROSCA24. Gleason score 6: should we keep calling it cancer?

Presenter: Roderick van den Bergh

  • No But we need surveillance
  • It doesn’t metastasize
  • 14% upgrading 1
  • 2-24% true progression
  • Use of risk factors could estimate the risk of true cancer.”

Gleason score

For more updates, follow OncoDaily.

Bárbara Melão cancer Manaus Adventist Hospital Memorial Sloan Kettering metastasize OncoDaily Oncology risk of cancer Roderick van den Bergh